Low molecular weight oligomers of amyloid beta (Ab) are important drivers of Alzheimer's disease. A decrease in Ab monomer levels in human cerebrospinal fluid (CSF) is observed in Alzheimers' patients and is a robust biomarker of the disease. It has been suggested that the decrease in monomer levels in CSF is due to the formation of Ab oligomers. A robust technique capable of identifying Ab oligomers in CSF is therefore desirable. We have used fluorescence correlation spectroscopy and a five Gaussian distribution model (5GDM) to monitor the aggregation of Ab 1-42 in sodium phosphate buffer and in artificial cerebrospinal fluid (ACSF). In buffer, several different sized components (monomer, oligomers, protofibrils and fibrils) can be identified simultaneously using 5GDM. In ACSF, the faster kinetics of fibrillogenesis leads to the formation of fibrils on very short timescales. This analysis method can also be used to monitor the aggregation of other proteins, nanoparticles or colloids, even in complex biological fluids.
Introduction
The accumulation of fibrils formed from the amyloid beta-protein (Ab) is a defining pathological hallmark of Alzheimer's disease (AD) [1] . However, recent evidence suggests that low molecular weight (M W ) diffusible aggregates of Ab (commonly referred to as Ab oligomers) are more important drivers of AD than the Ab fibrils found in amyloid deposits [2] [3] [4] . Several studies have shown that small protein aggregates are cytotoxic and contribute to synaptic dysfunction [5] [6] [7] [8] [9] [10] . In nature, there are at least 20 different Ab alloforms all of which have the same common core of about 30 residues, but differ in the length of their N-and C-termini [11] . Within this family of peptides, primary sequences terminating at Ala42 are particularly associated with AD [12] .
A lowering of Ab monomer levels in human cerebrospinal fluid (CSF) has been widely validated as a robust biomarker for the diagnosis of AD [13] , including in pre-symptomatic individuals that subsequently developed AD [14, 15] . Mechanistically, the progressive accumulation of both soluble and insoluble Ab aggregates has been postulated to explain the decline in Ab monomer observed in CSF. Consequently, it is believed that measurement of Ab oligomer levels in CSF could offer an even more sensitive indicator than current biomarkers [13] . Despite intense efforts there are currently no validated, reliable and sensitive means to detect Ab oligomers in CSF. The oligomerization and subsequent formation of protein fibrils of Ab is a complex interplay of many peptides and mechanisms and is not yet fully understood [16] [17] [18] [19] [20] . However, the majority of studies find that the mechanism for fibrillogenesis is consistent with a nucleation-dependent polymerization model [5, 18, 21] as illustrated in Fig. 1(A) . More recent work has suggested that a second nucleation step occurs [22] .
The major difficulty in monitoring the progression of Ab fibrillogenesis is the range of particles sizes present. Even at the early stages of fibrillogenesis Ab will exist as monomer, heterogenous oligomers, protofibrils and fibrils. Few techniques can measure and track the components of such a heterogenous mixture of different sized species simultaneously. Several methods have been used to map the progression of peptide aggregation, from monomer to fibril, including, high performance liquid chromatography, gel electrophoresis, atomic force microscopy, transmission electron microscopy (TEM), Thioflavin T assays, dynamic light scattering and others [16] . Monomeric Ab has a hydrodynamic radius (R h ) of 0.9 ± 0.1 nm [23] , while oligomeric and fibril forms range in size from several nanometers to several microns [16] [17] [18] [19] .
It is challenging to quantitatively measure the sizes of different oligomers, which co-exist with Ab monomer, protofibrils and fibrils during a typical measurement. Fluorescence correlation spectroscopy (FCS) can be used to differentiate multiple components in a polydisperse solution and has already been used to study the aggregation of other amyloidogenic proteins. Notably, the aggregation of polyglutamine in cells [24] , a-synuclein aggregation [25] and its binding to vesicles [26] have been studied. In relation to Ab, FCS has been used to establish an in vitro saturation concentration of Ab [27] , to test the interaction with aggregation inhibitors [28] and membranes [29, 30] , to study the depletion of oligomers under physiological conditions [23] and to determine the size distribution of Ab aggregates in solution [27, 31, 32] . Garai et al. [27] used a maximum entropy fitting method (MEM-FCS), which allowed multiple aggregating species within the system to be analyzed. While this is an improvement over standard fitting methods, it did not distinguish clearly between the oligomeric species in solution. Therefore, a need for a fitting procedure which can distinguish more clearly the different sized forms of Ab during fibrillogenesis exists.
Here, we have approached this problem by defining several sizes ranges (up to five) as Gaussian profiles (5GDM) and using these to fit the FCS autocorrelation function. This allows each pre-defined component to be fit to the data simultaneously, allowing more of the different sized components in the aggregating system to be determined at any particular time point during the experiment. The size distributions obtained using 5GDM analysis are compared to those obtained using MEMFCS. To our knowledge no previous work has used such a high number of Gaussian-shaped peaks and the same free variables for analysis of FCS data for polydisperse systems. This approach is not specific to Ab, and we expect that it will be readily applied to study of other aggregating or amyloidogenic proteins.
Material and methods

Sample preparation
Synthetic Ab was purchased from W. M. Keck Biotechnology Facility at Yale University and Hilyte Fluor488™ labeled Ab 1-42 was purchased from Anaspec Inc., Fremont (CA). The latter was dissolved in 1% NH 4 OH and diluted to a final concentration of 1 mg/ ml in 10 mM sodium phosphate buffer [33] . Ab 1-42 was dissolved in 0.1% NH 4 OH and then diluted with 100 mM Tris buffer at 1 mM, aliquoted and stored at À20°C. Once thawed, peptide solutions were centrifuged at 100,000g and 4°C for 1 h in a Beckman Optima Max XP ultracentrifuge (Indianapolis, IN) to remove preexisting fibrils. The upper 75% of the supernatant was collected and the concentration of Ab determined by absorbance at 275 nm. Thereafter the supernatant was further diluted to the desired concentrations using 10 mM sodium phosphate buffer or artificial CSF (119 mM NaCl, 26.2 mM NaHCO 3 , 2.5 mM KCl, 1 mM NaH 2 PO 4 , 1.3 mM MgSO 4 À -7H 2 O, 11 mM D-(+)-Glucose and 2.5 mM CaCl 2 .2H 2 O, pH adjusted to 7.3-7.4).
FCS experiments
FCS measurements were performed on a LSM10 microscope equipped with a ConfoCor2 unit (Carl Zeiss Jena, Germany), a 488 nm Argon laser and an apochromatic 40Â water-immersion objective with a NA of 1.2. Fluorescence emission was separated from laser light using a bandpass filter (505-550 nm). Calibration was performed with Alexa 488 to determine the dimensions of the observation volume. Samples were filled in NUNC 8-Well-Plates (Thermo Scientific), which were coated with 15 lg/ml poly-L-lysine (Biochrom AG). All measurements were performed at room temperature. Autocorrelation functions obtained from FCS measurements were analyzed as described in Supplementary information.
Results and discussion
Aggregation of Ab 1-42 in sodium phosphate buffer
The aggregation of Ab 1-42 was measured at 10 and 20 lM in the presence of 0.01% labeled Ab 1-42 in 10 mM sodium phosphate buffer, pH 7.4 by FCS. Variability in the time before onset of oligomer formation can depend on preparation conditions [16] , and/or additional stresses applied to the sample to speed up the process [25, [34] [35] [36] . Measurements were taken systematically over 48 h using consistent preparation methods to minimize these effects. Fig. 2 shows the evolution of an autocorrelation function over the time course of a typical experiment. This sample, at 20 lM, indicates that higher M W species appear over several hours, indicated by a shift in the delay time to higher values.
Comparison of MEMFCS and 5GDM fitting
Beyond the first few measurements, a one-component fit (SI Eq. (2)) leads to unsatisfactory and physically unrealistic results (not shown). Thus, a more sophisticated fitting method is required. (0.01% labeled). During the experiment the curves shift to the right and a buckling develops, indicating an increase in the number of different species and of particle sizes.
We first applied the MEMFCS fitting method [27, 37] to autocorrelation functions at different time points throughout the experiment (Fig. 3A) . A fit of the first measurement, reveals a single peak with a R h maximum at 1.44 nm and a shoulder towards larger hydrodynamic radii. After 48 h, three peaks corresponding to spherical hydrodynamic radii of 2.09 nm, 101.17 nm and 4.5 lm were observed (Fig. 3E) . Due to the assumption of maximum uncertainty and to avoid over interpretation of the data, MEMFCS fitting finds the widest size distribution that is consistent with the data [37] . Thus, the broad peaks obtained with MEMFCS are likely to include size distribution data for several different species in solution. Distribution curves resulting from MEMFCS analysis show Gaussian-type distribution features. Therefore, we used a Gaussian-shaped size distribution with a fixed number of peaks to fit our experimental data. This was inspired by initial work by Pal et al. [38] , who used this approach as an alternative to MEMFCS for microemulsion droplets. The idea is that a component is not monodisperse with a single value for the diffusion time, s D , but rather a Gaussian distribution on a logarithmic time-scale with a peak diffusion time s P . The fit to the autocorrelation function is described by:
with the amplitude distribution
where A n is the relative amplitude of the components, s Pn is the 
Hence, each distribution in the Gaussian distribution model (GDM) will represent a narrow range of particle sizes. The validity of the GDM was verified by extensive testing of the well-known dye Alexa 488 (using one distribution successfully, whereas a higher number of distributions were rejected by the model correctly). We choose to use five peaks for the fitting of Ab since this was a good balance between distinguishing the different species in solution (monomer, small oligomer, larger oligomer, protofibril and fibril) and not having so many free variables that the outcome of the fits was physically unrealistic. Analysis of many autocorrelation curves using this method, gave consistent results. Less than five peaks led to an inappropriate description of the system (i.e. component sizes smaller than monomeric Ab concomitant with very large particles at early time points).
In Fig. 3B the results of the analysis with the 5GDM are presented. There are a larger number of more sharply defined peaks representing different levels of Ab 1-42 aggregation than for MEM-FCS. 5GDM fits reveal that two peaks at 1.17 nm and 1.62 nm are present at early time points in the experiment. If a weighted sum of these first two peaks is calculated using the relative amplitudes, a R h of 1.44 nm is determined. This corresponds exactly to the diffusion time for the first peak obtained using MEMFCS fitting. In the reasonable measureable range for FCS and the values are artifacts of the fitting procedure in both methods. A comparison of the results obtained for each fitting procedure is shown in Fig. 3C -E. Clearly the general features of the aggregating system are consistent using both methods, but the 5GDM provides a more detailed and potentially a more realistic description of the aggregating system with better resolution of low M W species.
Evaluation of the four fractions of Ab 1-42 aggregates
5GDM reveals a larger number of species within the system than MEMFCS, but each of these species represents a range of particle sizes. Since the first two peaks fuse and separate several times during the experiment, it was impossible to analyze these fractions separately ( Fig. 3D and E) . Hence, the percentages of the first two peaks were pooled and treated as one. This leads to a four level fraction model for Ab 1-42 aggregation (although a five peak fitting formula is used). The fusion of these first two peaks is probably due to a dynamic equilibrium that is assumed between monomers and very small oligomers [39, 40] . We have therefore defined each of the size ranges obtained from the fitting as: (1) small components including monomers and low M W oligomers; (2) higher M W oligomers; (3) protofibrils and (4) fibrils. The fractions of the various Ab particles in solution were determined from the 5GDM fitting and calculated using Eq. (3). The fractions were monitored over time and the averaged values are shown in Fig. 4 .
The rate of aggregation is slower in the lower concentration samples and is consistent with previous experiments [32] . After 48 h, the proportion of fraction 1 (monomer and small oligomers) is higher in the lower concentration samples (72.4 for 10 lM compared to 64.9% for 20 lM), with a corresponding lower proportion of fibrils (3.6% for 10 lM and 7.5% for 20 lM). The proportion of fraction 1 decreases as fibrillogenesis proceeds (Fig. 4) , while the R h stays relatively constant (Fig. S1) . Combined, these observations indicate a real decrease of the amount of monomer/small oligomers in solution. In Fig. S1 the evolution of the two peaks, which we have called fraction 1 (monomer and small oligomer) is shown. We observe that only a few data points lie in the monomer range between 0.8 and 1 nm [23] , and most of the data points lie between 1 and 2 nm. This size range represents mixtures of monomers and small oligomers. Therefore with 5GDM it is not possible to differentiate between monomers and small oligomers and hence we have pooled this data in fraction 1. However, we can clearly separate a mixture of monomers and low M W oligomers from larger aggregates. At the beginning of an experiment the dominating species are small components (Fig. 4) . This starting material consists of a mixture of monomer and small oligomers. Monomeric samples did not aggregate on a reasonable experimental time scale [23] . Examining fraction 2 (higher Mw oligomers), we see that these remain constant throughout the experiment (Fig. 4) (14% for 10 lM and 19% for 20 lM). For this fraction, the R h grows slowly in size, and is in the range of 10 nm (Fig. S2) . Hence, before the first measurement, equilibrium between small components (fraction 1) and high M W oligomers (fraction 2) is established.
Protofibrils or fibrils are not present in FCS data at the beginning of the experiment (Fig. 4) , but appear after a lag time, consistent with a nucleation-dependent polymerization model [41] . Both species show a sigmoidal behavior and a mean lag time of $16 h. The fraction of protofibrils reaches a saturation level of 10% at 20 lM and 8% at 10 lM, respectively, while the proportion of fibrillar material continues to increase to the end of the experiment. Transmission electron microscopy (TEM) confirmed fibril formation (Fig. S3) . The presence of fibrils is consistent with 5GDM analysis and the size values obtained for fibrils are in agreement with published studies [5, 42, 43] .
Preliminary experiments in artificial CSF
Using artificial cerebrospinal fluid (ACSF), we assessed if the 5GDM fitting procedure is suitable for analysis in complex buffers and potentially in biological fluids. Large sedimenting particles are observed immediately after mixing stock Ab with ACSF. During FCS measurements, this manifests as decreasing particle numbers due to loss of material to the large aggregates. The remaining monomeric material, now at much lower concentration, does not proceed to form higher M W oligomers, since it is below the concentration required for the onset of fibrillogenesis. The higher ionic strength of ACSF leads to much faster kinetics for fibrillogenesis of Ab in lM concentrations [36] . An incremental decrease in Ab, to nM concentrations, failed to find a regime in which a broader distribution of particles sizes was observed. Furthermore, adding labeled Ab to pre-aggregated samples in ACSF produced similar results. In these experiments, only single events in the count rate plots were observed for 1 lM, 500 nM and 50 nM Ab , and these bursts corresponded to fibrils rather than to oligomers. A systematic evaluation with 5GDM was not performed, since these single events do not meet the requirements of the statistical basis needed for quantitative FCS analysis. These observations are consistent with Nag et al. [23] . They suggested that Ab 1-42 aggregation is dependent on physiological factors at low concentrations of Ab and that aggregates dissociate below a certain concentration because they are thermodynamically unstable. However, beyond the limitation of this experimental system, there are no technical barriers to using 5GDM analysis in ACSF, CSF or other complex biological fluids.
A new fitting procedure for FCS (5GDM), allowing several different sized components in solution to be analyzed simultaneously has been developed to study the fibrillogenesis of Ab . Four Ab 1-42 aggregate types in solution were identified; small components (including monomer and low molecular weight oligomers), high M W oligomers, protofibrils and fibrils. Each component was observed in solution over 48 h for a range of protein concentrations. A comparison with MEMFCS analysis confirmed that the results obtained with 5GDM are consistent with the established method, but that better resolution of particle size distributions in the nm range were obtained using 5GDM. Given that oligomers of Ab in CSF have been found at picogram levels [44] , concentration of the sample to pM levels could facilitate measurements in CSF using FCS with 5GDM. This analysis method could also be usefully employed to monitor the aggregation of other proteins, nanoparticles and colloids. 
